ALKS - Alkermes succeeds in early-stage trial for sleeping disorder therapy
2024-04-09 08:13:22 ET
More on Alkermes
- Alkermes plc 2023 Q4 - Results - Earnings Call Presentation
- Alkermes plc (ALKS) Q4 2023 Earnings Call Transcript
- Alkermes: Additional Narcolepsy Data Could Lead The Way To The Next Stage
- Baird starts Alkermes at outperform, citing revenue stream
- Alkermes downgraded at UBS as stock nears 52-week high